Student team from Johns Hopkins places first at Wake Forest biotech competition

Representatives from five JHU schools bring home $10,000 top prize

Image caption: Johns Hopkins team members (from left) Paloma Navas Gutierrez, Matthew Koch, Ying-Ying Wang, team leader Po-Yuan (Robert) Hsiao, and Yuanming Suo.

Credit: Allen Aycock / Wake Forest University School of Business

For the second consecutive year, a team of students from Johns Hopkins University won the $10,000 first prize in the Biotechnology Conference and Case Competition at Wake Forest University in Winston-Salem, N.C.

Image caption: Johns Hopkins team members (from left) Paloma Navas Gutierrez, Matthew Koch, Ying-Ying Wang, team leader Po-Yuan (Robert) Hsiao, and Yuanming Suo.

Image credit: Allen Aycock / Wake Forest University School of Business

The JHU student team consisted of:

  • Matthew Koch, a member of the 2014 class of the Carey Business School's Global MBA program
  • Paloma Navas Gutierrez, a PhD candidate in health policy and management at the Bloomberg School of Public Health
  • Team leader Po-Yuan (Robert) Hsiao, a PhD candidate in pharmacology at the School of Medicine
  • Yuanming Suo, a PhD candidate in electrical engineering at the Whiting School of Engineering
  • Ying-Ying Wang, a postdoctoral fellow in biophysics at the Krieger School of Arts and Sciences

Other schools that took part in the fifth annual competition, held in late March, were Virginia Tech (winner of $5,000 for second place), Ohio State (winner of the $2,000 third-place prize), Duke, North Carolina State, the University of California at Berkeley, Boston University, and Wake Forest.

In the competition, the eight student teams were challenged by lead sponsor Boston Scientific to create methods of improving value for patients in the company's endoscopy division. The teams worked on their proposals for a week and then spent one day presenting them to a group of judges.

Wang said the JHU team benefitted from the strengths of the members' varied academic backgrounds.

Added Koch: "We wanted to provide innovative solutions, so some of our recommendations entailed risk. But our rationale was solid, and we quantified the payoffs to demonstrate the value to Boston Scientific."

Read more from Carey Business School